Implementation and new biomarker development for Personalised Medicine for Childhood Cancers in Spain

Moreno Martin Retortillo, Lucas (Principal Investigator)

Vall d'Hebron Research Institute

Status	Finished
Effective start/end date	1/01/22 → 31/12/25

Collaborative partners

Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ) (Project partner)
Institute of Biomedicine of Seville (IBiS) (Project partner)
La Fe University and Polytechnic Hospital (Project partner)
Vall d'Hebron Research Institute (lead)

Funding

Institute of Health Carlos III (ISCIII): €369,260.00